Skip to content

Welcome to Discover Pharma! Today is : November 14, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Immuno Oncology

  • Clinical & Regulatory,Drug Delivery & Formulation,Drug Discovery & Development,Opinion & Events,Therapeutic Areas

    Can cryoablation plus intratumora immunotherapy rewrite the rules of cancer treatment?

    Q&A with Dr Jason Williams, founder of the Williams Cancer [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development

    Domain Therapeutics shares updates on immuno-oncology programs at AACR 2025

    May 5, 2026
  • Advanced Therapies

    Cellistic unveils Echo-NK platform to scale up iPSC-based cell therapies

    May 5, 2026
Previous23

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • AbbVie expands Oxford R&D with new research facility
    Categories: Biotech & Pharma Business, Drug Discovery & Development, Research & Development
  • Rare disease survey finds high levels of depression and anxiety
    Categories: Therapeutic Areas
  • Lonza to acquire five US CDMO sites from Merck
    Categories: Advanced Therapies, Biotech & Pharma Business, Drug Delivery & Formulation, Manufacturing & Supply Chain
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top